Real-time enrollment status for this atopic dermatitis (ad) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 6:40 AM UTC
| NCT Number | NCT07453602 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis (AD) |
| Phase | PHASE1 |
| Target Enrollment | 125 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Arcutis Biotherapeutics, Inc. |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07453602 is currently recruiting participants. This phase1 study for atopic dermatitis (ad) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Arcutis Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07453602 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07453602 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.